SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-063516
Filing Date
2024-05-20
Accepted
2024-05-20 17:29:59
Documents
2
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2414893-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2414893-1_3seq1.xml 3 1627
2 EXHIBIT 24.1 tm2414893d1_ex24-1.htm EX-24.1 8632
  Complete submission text file 0001104659-24-063516.txt   11871
Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hohneker John (Reporting) CIK: 0001695378 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41929 | Film No.: 24966011

Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Issuer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)